Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Myeloid 1 Genitourinary 1 CNS 1

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 191 pembrolizumab 155 Pemetrexed 134 Cisplatin 117 durvalumab 71 Paclitaxel 71 osimertinib 67 Nivolumab 66 Docetaxel 63 Specimen Handling 61 atezolizumab 57 Magnetic Resonance Spectroscopy 50 Etoposide 46 Gemcitabine 42 Radiotherapy 39 Radiosurgery 37 130-nm albumin-bound paclitaxel 34 Drug Therapy 30 Cetuximab 28 Bevacizumab 27 Ipilimumab 25 Taxes 23 cemiplimab 22 tislelizumab 20 Platinum 20 amivantamab 18 Radiation 18 Immunoglobulin G 17 1,2-diaminocyclohexaneplatinum II citrate 17 Disulfides 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Quality of Life × Thoracic × 90 days × Clear all

NCT06646471 2026-04-29

PROMETHEE

Groupe Francais De Pneumo-Cancerologie

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡